fbpx

Analys

PROLIGHT: SEK 17m UK grant a welcome external validation

Analys, Research

Prolight’s report for Q1’24 did not reveal any particular surprises. The positive SEK 5.6m revision to the FY’23 result stemming from...

Read More

AGTIRA: Mixed start to pivotal 2024

Analys, Research

As announced already in February, capacity utilization and turnover in Q1 were weighed down by the plant disease in Härnösand, with a...

Read More

NANEXA: Insights from CMD underscore near- to mid-term opportunities with significant potential

Analys, Research

Apart from a slight further delay in the start of Phase I with NEX-22, the report for Q1’24 proved rather uneventful. The subsequent CMD...

Read More

GRANGEX: Striking renegotiation of Sydvaranger acquisition setting GRANGEX up for an eventful 2024

Analys, Research

With a striking renegotiation of the final purchase agreement for Sydvaranger, reducing the initial payment from USD 1+19m to USD 1+0.5m,...

Read More

MOTION DISPLAY: Another strong quarter confirming that MODI has turned the corner

Analys, Research

MODI reported sales growth in Q1’24 of 31%, confirming that the strong momentum seen in H2’23 carried into 2024. Along with a 4ppt...

Read More

CRUNCHFISH: Broadening of scope to all offline credentials

Analys, Research

Johan Widmark | 2024-05-03 12:00  READ FULL REPORT IN PDF HERE Following the app-integrated offline payments with Digital Cash, and recent...

Read More

PROLIGHT: Important milestone amidst mixed news flow

Analys, Research

There has been a somewhat mixed news flow from Prolight after the close of Q1’24. The finalization of the cartridge design to be used on...

Read More

CRUNCHFISH: Major TAM expansion with broadening to secure and scalable mobile card payments

Analys, Research

Johan Widmark | 2024-03-27 12:00  READ FULL REPORT IN PDF HERE With the broadening of its Digital Cash technology to support secure...

Read More

PROLIGHT: PoC troponin testing ready for next step

Analys, Research

With proof-of-performance for its proprietary digital technique for detection of high-sensitive biomarkers even in whole blood, Prolight...

Read More

GRANGEX: Starting to fuel up: GRANGEX set for busy agenda in 2024 

Analys, Research

With the SEK 74 m (estimated 61m net) proceeds from the rights issue, we now look forward to the updated feasibility study initiated in...

Read More

For new research on growth stocks, sign up to our newsletter